upsid price
return equiti ltm
solid result outlook slightli better expect
increas price
top line varian report revenu million versu estim
million consensu estim million look revenu
oper segment oncolog system revenu came million
versu estim million proton solut segment deliv
million versu estim million gross oncolog order
increas except rate report constant
currenc proton solut busi book new order
outlook varian provid solid financi guidanc includ
revenu growth adjust ep rang flow
oper expect track million million full-
year non-gaap effect tax rate expect
weight averag share count around million final
varian guidanc includ impact current enact tariff
includ assumpt regard potenti futur
bottom line varian report adjust ep figur quarter
versu street-low expect consensu estim
stronger-than-expect revenu lower-than-expect oper expens
among primari reason posit adjust ep surpris rel
model
balanc sheet cash flow varian end quarter cash
equival approxim million debt flow
oper quarter roughli million came million
overal
recommend maintain outperform invest rate
share increas price target previou
arriv price target attach multipl adjust ebitda
estim assum million net cash month
revenu mil estimate bold
ep estimate bold
note pleas refer page end
report import disclosur
overal varian medic deliv strong fiscal fourth quarter overal revenu
easili beat expect well consensu adjust ep slightli
exceed street-low estim fall short consensu estim
import note adjust estim tri account
recent tariff activ certain cover firm taken action
prior last night earn report compani gross order oncolog
quarter strong constant currenc report final
varian provid slightli better-than-expect financi guidanc rel
revenu profit
revenu look revenu oper segment oncolog system revenu came
million easili beat estim million compani
revenu segment increas around product revenu
quarter servic increas
varian proton solut segment deliv million revenu declin
versu compar quarter last year estim busi
gross margin oper expens total consolid gross margin came
versu estim oncolog system gener gross
margin improv bp gross margin remain well
report sg expens quarter came revenu versu
model
 expens revenu versu model
profit adjust ep came bit better
estim fell short consensu estim
balanc sheet cash flow varian end quarter cash equival
approxim million debt flow oper total roughli
varian report solid fourth quarter result view compani revenu
easili beat estim well consensu adjust ep result narrowli
exceed expect though fell bit short consensu estim
importantli order momentum strong increas
constant currenc within oncolog segment final manag provid solid
guidanc term revenu growth profit cash flow given
overhang china tariff issu believ guidanc provid
measur relief investor
varian financi guidanc includ expect overal
revenu growth adjust ep oper cash flow
million current model adjust ep revenu growth
cash flow expect also consist varian guidanc
manag state financi impact associ china retaliatori tariff
late august million revenu adjust ep quarter
impact captur previou manag guidanc
compani see million gross impact includ million revenu
relat tariff issu compani unabl receiv exempt
trump administr said manag believ compani
mitig gross figur via variou lever includ suppli chain
re-phas certain project mitig effort take place
first half result adjust ep cadenc weight
toward second half consist model net basi total
adjust ep drag associ issu mitig effort equat around
import astro confer held week varian util
backdrop announc format consortium studi potenti ultra-high
dose rate cancer treatment flash earli pre-clin work appear excit
seem hold promis amazingli quick treatment throughput attack
cancer tumor larg spare healthi tissu compani surprisingli
believ initi could prove groundbreak time
compani also discuss develop work multimod
adapt radiotherapi suit driven artifici intellig promis
enhanc clinic decision-mak deliveri patient radiat therapi
regimen believ effort could help compani meaning compet
marketplac
introduct astro includ bravo brachytherapi afterload
system improv simplifi patient treatment increas workflow
effici probeam single-room proton therapi system come
consider smaller footprint cheaper term vault construct
cost compar previou system
quarter oncolog system revenu increas dollar
constant currenc result larg driven revenu growth emea
region asia-pacif region also show solid growth final oncolog
busi america
oncolog order also strong quarter increas america
order increas order north america europ middl east
africa region gross oncolog order increas final gross oncolog order
asia-pacif region australia china japan show strength
quarter region
varian gross margin within oncolog busi declin bp
quarter chines tariff issu play part disappoint result
bp continu weigh gross margin exclud
posit exempt decis trump administr
varian state continu lobbi trump administr exempt
recent tariff activ disclos sens decis
file could come import note compani guidanc assum relief
provid area throughout balanc thu posit decis
would repres upsid current financi guidanc
compani absolut break-out quarter term halcyon order
quarter order bring total sinc product first unveil vienna
may order halcyon quarter place spain
scandinavia russia africa japan australia list exhaust
believ uptick order flow would come point pickup recent
order momentum compani halcyon busi still highli encourag
market effort custom endors clearanc system
kilovoltag cone beam ct imag key tender win cite manag
reason strong result
compani continu see strong demand softwar solut revenu
increas rapidplan exhibit noteworthi strength deliv
varian proton solut busi gener million revenu
quarter book new busi three quarter sinc new order
book within busi margin also remain well compani averag
due part still rel modest footprint busi kolleen kennedi
compani new chief growth offic also lead compani proton
busi state astro yesterday book new order achiev scale
within proton busi top two prioriti go forward
varian continu activ share repurchas activ repurchas
approxim million share quarter share
compani still approxim million share remain current share
look intern invest elev capit alloc prioriti
rel share repurchas throughout said expect compani
engag rel modest amount share repurchas throughout year
maintain outperform invest rate share
increas price target arriv price target attach
multipl adjust ebitda estim assum million net
cash month
revenu
interest incom net
 revenu
sg revenu
pre-shar repo chg wc
million except per share data
ex pec ted outperform mark et next ont hs
sound im prov ing com pani fundament
potenti exi ts near- ter atali st
underv alu curr ent level
ex pec ted perform oughli line ark et ov er nex month
long-term potenti ex ts near -term catalyst appar
fairli alu curr ent level
ex pec ted under-perform ar ket nex onth
com pani fundam ental ay deterior ate
fulli alu over- valu cur rent level
dev elop pric tar get com pani use /e itda howev
ri ks target pric ac hiev he inc lude limit failur
 om pani eet revenu earn estim ate
follow list rate com pani cov ere ar rington earch soc iat
inc septem ber number om pani rate pe rfo rm
 epr esent com pani age li num ber com pani rate
rk et rfor epr esent com pani cover age li
num ber com pani rate pe rfor epr esent
com pani cov erag li lso eptem ber bar rington researc
sociat inc pr ovid inv tment bank serv ic es within last onth
com pani utp erf orm rate com pani
ark pe rfo rm rate
 ompani
analyst certif icat ion re ear ch analyst respons prepar researc report ichael petusk cfa herebi ertifi
 iew om pani sec ur iti expr sed epor acc urat eflect per onal opinion analyst al
cer tifi part com pensat directli indir ec tli relat pecif recom endat iew contain report
researc anali st inc lude tho inv olv ed pr epar ation epor receiv direc com pen ation onnec tion firm
inv estm ent bank ing activ nali st om pensat ade alar bonu base upon num erou fact inc lude
stoc price perfor manc qualiti anali inv tor client feedbac well overal pr ofit firm whic im pact
firm busi ac tiv iti inc lude ong thing institut equiti trade inv estm ent bank ing ser vice
inv tment bank serv ic es defin na rule inc lude ong thing ac ting underwrit em ber
sell gr oup ec uriti write anali st re pon ibl report michael petusk cf ember analyst
household hare omm toc om pani na sd regul adopt rule prohibit researc anali st
trade ecur iti cov er ed om pani pecifi tim period befor public ation re ear ch report
 ar rington ear ch ss ociat inc full- serv ic financ ial serv ic es firm offer wide var ieti serv ic es product client
inv tor hould ass ume arringt ear ch eek ing eek investm ent bank ing bu ine elat hip
com pani es earc overag ar rington researc receiv inv estm ent bank ing-r elat com pen ation
com pani within pa onth expect within nex thr ee month
barrington research associ inc finra-regist broker/deal clear nation financi nf
fulli disclos basi conveni client offer sever way client facilit payment
trade barrington research order may place trade desk
trader michael hutchison head trader christoph cottrel email address
instant messeng address brrrmh
trade broker trade may also stepped-in barrington research trade execut broker
commiss share arrang barrington commiss share agreement numer broker wall
street complet list commiss share program barrington research particip pleas contact
salesperson trade desk
follow list provid barrington research trade alloc settlement id nf dtc code execut
question trade set account relat inform pleas call trade depart
inform contain herein obtain sourc believ reliabl guarante accuraci complet
opinion estim reflect best judgment report date subject chang without notic report intend inform
purpos constitut offer solicit buy sell secur barrington research associ inc affili offic
analyst employe may time time posit secur refer herein barrington research associ inc may act
princip agent buyer seller purchas sale secur mention report barrington research associ
inc may provid may seek provid invest bank servic compani mention report report may
reproduc form without prior written consent barrington research associ inc right reserv member finra/sipc
